| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| Q99NB2 | Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase; EC 2.4.1.206; Lactotriaosylceramide synthase; Lc(3)Cer synthase; Lc3 synthase; UDP-GlcNAc:beta-Gal beta-1,3-N-acetylglucosaminyltransferase 5; BGnT-5; Beta-1,3-Gn-T5; Beta-1,3-N-acetylglucosami癷?癸 | B3gnt5; | NP_446384.1;XP_008767071.1; | 377 | rat |
| Q66H69 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7; BGnT-7; Beta-1,3-Gn-T7; Beta-1,3-N-acetylglucosaminyltransferase 7; Beta3Gn-T7; EC 2.4.1.-; | B3gnt7; | NP_001012134.1; | 397 | rat |
| Q6GV29 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1; BGnT-like protein 1; Beta1,3-N-acetylglucosaminyltransferase-like protein 1; Beta3Gn-T-like protein 1; Beta3GnTL1; EC 2.4.1.-; | B3gntl1; | NP_001015035.1;XP_008766727.1;XP_008766728.1;XP_008766729.1;XP_008766730.1; | 357 | rat |
| O88178 | Beta-1,3-galactosyltransferase 4; Beta-1,3-GalTase 4; Beta3Gal-T4; Beta3GalT4; b3Gal-T4; EC 2.4.1.62; Gal-T2; Ganglioside galactosyltransferase; UDP-galactose:beta-N-acetyl-galactosamine-beta-1,3-galactosyltransferase; | B3galt4; | NULL | 371 | rat |
| Q10468 | Beta-1,4 N-acetylgalactosaminyltransferase 1; EC 2.4.1.92; (N-acetylneuraminyl)-galactosylglucosylceramide; GM2/GD2 synthase; GalNAc-T; | B4galnt1; Galgt Galgt1; | NP_074051.1; | 533 | rat |
| P80225 | Beta-1,4-galactosyltransferase 1; Beta-1,4-GalTase 1; Beta4Gal-T1; b4Gal-T1; EC 2.4.1.-; UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1; UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1; Fragments; EC 2.4.1.-; EC 2.4.1.38; Nal癷?癸 | B4galt1; Ggtb2; | NULL | 32 | rat |
| Q6P768 | Beta-1,4-galactosyltransferase 3; Beta-1,4-GalTase 3; Beta4Gal-T3; b4Gal-T3; EC 2.4.1.-; UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 3; UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 3; EC 2.4.1.-; EC 2.4.1.38; Nal synthase; 癷?癸 | B4galt3; | NP_001009539.1;XP_006250315.1;XP_006250316.1; | 395 | rat |
| Q66HH1 | Beta-1,4-galactosyltransferase 4; Beta-1,4-GalTase 4; Beta4Gal-T4; b4Gal-T4; EC 2.4.1.-; UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 4; UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 4; Beta-N-acetylglucosaminyl-glycolipid be癷?癸 | B4galt4; | NP_001012018.1; | 344 | rat |
| O88419 | Beta-1,4-galactosyltransferase 6; Beta-1,4-GalTase 6; Beta4Gal-T6; b4Gal-T6; EC 2.4.1.-; UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 6; UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 6; UDP-Gal:glucosylceramide beta-1,4-galac癷?癸 | B4galt6; | NP_113928.1; | 382 | rat |
| P0C5J2 | B9 domain-containing protein 1; Endothelial precursor cells protein B9; | B9d1; Eppb9; | NP_001099256.1;XP_003750891.1; | 204 | rat |
| P0C5J3 | B9 domain-containing protein 2; | B9d2; | NP_001100964.1;XP_006228500.1; | 175 | rat |
| Q920K5 | Brain and acute leukemia cytoplasmic protein; | Baalc; | NP_658907.1; | 145 | rat |
| Q63276 | Bile acid-CoA:amino acid N-acyltransferase; BACAT; BAT; EC 2.3.1.65; Glycine N-choloyltransferase; Kan-1; Long-chain fatty-acyl-CoA hydrolase; EC 3.1.2.2; | Baat; | NP_058996.2; | 420 | rat |
| Q5XIJ6 | BRISC and BRCA1-A complex member 1; Mediator of RAP80 interactions and targeting subunit of 40 kDa; New component of the BRCA1-A complex; | Babam1; Merit40 Nba1; | NP_001006965.1;XP_006252919.1; | 334 | rat |
| Q7TNY1 | BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2; BTB/POZ domain-containing protein TNFAIP1; Tumor necrosis factor-induced protein 1; | Tnfaip1; | NP_891995.1; | 316 | rat |
| Q7TPL3 | BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3; BTB/POZ domain-containing protein KCTD10; | Kctd10; | NP_001009973.1; | 315 | rat |
| P56819 | Beta-secretase 1; EC 3.4.23.46; Aspartyl protease 2; ASP2; Asp 2; Beta-site amyloid precursor protein cleaving enzyme 1; Beta-site APP cleaving enzyme 1; Memapsin-2; Membrane-associated aspartic protease 2; | Bace1; Bace; | NP_062077.1; | 501 | rat |
| Q6IE75 | Beta-secretase 2; EC 3.4.23.45; Beta-site amyloid precursor protein cleaving enzyme 2; Beta-site APP cleaving enzyme 2; Memapsin-1; Membrane-associated aspartic protease 1; Theta-secretase; | Bace2; | NP_001002802.1; | 514 | rat |
| Q64559 | Cytosolic acyl coenzyme A thioester hydrolase; EC 3.1.2.2; ACH1; ACT; Acyl-CoA thioesterase 7; Brain acyl-CoA hydrolase; BACH; CTE-IIa; CTE-IIb; CTE-II; LACH1; Long chain acyl-CoA thioester hydrolase; MTE-II; | Acot7; Bach; | NP_001139533.1;NP_037346.2; | 381 | rat |
| O35147 | Bcl2-associated agonist of cell death; BAD; Bcl-2-binding component 6; Bcl-xL/Bcl-2-associated death promoter; Bcl2 antagonist of cell death; | Bad; | NP_073189.1;XP_006230958.1; | 205 | rat |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |